Cipla rises on launching generic Nintedanib for treatment of IPF

21 Oct 2020 Evaluate

Cipla is currently trading at Rs. 767.35, up by 3.30 points or 0.43% from its previous closing of Rs. 764.05 on the BSE.

The scrip opened at Rs. 782.80 and has touched a high and low of Rs. 782.80 and Rs. 759.80 respectively. So far 122826 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 829.00 on 13-Oct-2020 and a 52 week low of Rs. 356.75 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 787.80 and Rs. 756.45 respectively. The current market cap of the company is Rs. 61965.18 crore.

The promoters holding in the company stood at 36.68%, while Institutions and Non-Institutions held 39.92% and 23.40% respectively.

Cipla has launched generic Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Available as 100 mg and 150 mg capsules, it will be marketed under the brand name Nintib. This launch marks yet another milestone in Cipla’s decade-long commitment to treat IPF, a rare lung disease that impacts ten in one lakh people.

Cipla’s journey in IPF began in 2010 with the introduction of Pirfenex, the world’s first generic Pirfenidone and the first ever approved drug for IPF in India. Further to this, company reduced the cost of its IPF therapy by 40% in 2013 to provide patient-access to this critical treatment. In line with its endeavour of enabling effective and affordable management of IPF, Cipla’s Nintib is priced at Rs 69 (100 mg) and Rs 85 (150 mg) per capsule.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1497.45 -23.10 (-1.52%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×